IFP Advisors, Inc

Position in PRTA — Prothena Corp Public Ltd Co

CIK 1641866 TAMPA, FL

Position in PRTA

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$1,634

+$1,489 QoQ

Shares Held

167

+1013.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#156

of 187 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

IFP Advisors, Inc holds $55,990,065 across 216 Biotechnology names. PRTA ranks #139 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	62,273	$15,242,562
2	TGTX	Tg Therapeutics, Inc.	209,318	$11,499,930
3	JAZZ	Jazz Pharmaceuticals plc	34,193	$8,239,487
4	AUPH	Aurinia Pharmaceuticals Inc.	361,634	$6,136,928
5	VKTX	Viking Therapeutics, Inc.	61,616	$2,403,640
6	EXEL	Exelixis, Inc.	43,101	$2,345,125
7	VRTX	Vertex Pharmaceuticals Inc / Ma	2,968	$1,474,294
8	REGN	Regeneron Pharmaceuticals, Inc.	1,352	$843,026

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,634	167	+1013.3%	Shares	Sole	2026-07-20
2026-03-31	$145	15	0.0%	Shares	Sole	2026-04-13
2025-12-31	$143	15	0.0%	Shares	Sole	2026-02-06
2025-09-30	$146	15	—	Shares	Sole	2026-02-06
2025-06-30	$5,536	0	-100.0%	Shares	Sole	2025-07-24
2025-03-31	$1,633	132	0.0%	Shares	Sole	2025-05-05
2024-12-31	$1,828	132	+560.0%	Shares	Sole	2025-02-04
2021-06-30	$1,028	20	+5.3%	Shares	Sole	2021-07-13
2021-03-31	$477	19	+11.8%	Shares	Sole	2021-04-30
2020-12-31	$204	17	-52.8%	Shares	Sole	2021-01-25
2020-09-30	$359	36	—	Shares	Sole	2020-10-29
2020-06-30	$0	0	—	Shares	Sole	2020-08-05
2020-03-31	$0	0	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.